Cargando…

RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m(6)A‐IGF2BP2‐dependent manner

BACKGROUND: Having emerged as the most abundant posttranscriptional internal mRNA modification in eukaryotes, N6‐methyladenosine (m(6)A) has attracted tremendous scientific interest in recent years. However, the functional importance of the m(6)A methylation machinery in ferroptosis regulation in hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Jing, Chen, Xiaozhen, Jiang, Xiaohua, Dong, Zhihuai, Hu, Sunhong, Xiao, Mang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279968/ https://www.ncbi.nlm.nih.gov/pubmed/35689537 http://dx.doi.org/10.1002/jcla.24514

Ejemplares similares

ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner
por: Ye, Jing, et al.
Publicado: (2023)

Low-Concentration PTX And RSL3 Inhibits Tumor Cell Growth Synergistically By Inducing Ferroptosis In Mutant p53 Hypopharyngeal Squamous Carcinoma
por: Ye, Jing, et al.
Publicado: (2019)

RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner
por: Guo, Xingya, et al.
Publicado: (2020)

RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A‐YTHDF2‐dependent manner
por: Shen, Dingcheng, et al.
Publicado: (2023)

m(6)A demethylase ALKBH5 attenuates doxorubicin-induced cardiotoxicity via posttranscriptional stabilization of Rasal3
por: Gao, Ri-Feng, et al.
Publicado: (2023)

ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner
por: Chen, Jinhao, et al.
Publicado: (2023)

Ferroptosis regulation by the NGLY1/NFE2L1 pathway
por: Forcina, Giovanni C., et al.
Publicado: (2022)

NFE2L1-mediated proteasome function protects from ferroptosis
por: Kotschi, Stefan, et al.
Publicado: (2022)

Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1
por: Huang, Chaoqing, et al.
Publicado: (2022)

The mechanism of the Nfe2l2/Hmox1 signaling pathway in ferroptosis regulation in acute compartment syndrome
por: Zheng, Tiejun, et al.
Publicado: (2022)

Novel genetic alterations and their impact on target therapy response in head and neck squamous cell carcinoma
por: Jiang, Xiaohua, et al.
Publicado: (2019)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2(V617F) mutated cells
por: Staehle, Anne Marie, et al.
Publicado: (2023)

IGF2BP3 is an essential N(6)-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
por: Xu, Xin, et al.
Publicado: (2022)

Ferroptosis-related NFE2L2 and NOX4 Genes are Potential Risk Prognostic Biomarkers and Correlated with Immunogenic Features in Glioma
por: Lin, Li, et al.
Publicado: (2023)

METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner
por: Lu, Jiawei, et al.
Publicado: (2023)

lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
por: An, Lifeng, et al.
Publicado: (2022)

NFE2L2 polymorphisms, mortality, and metabolism in the general population
por: Figarska, Sylwia M., et al.
Publicado: (2014)

CNC-bZIP protein NFE2L1 regulates osteoclast differentiation in antioxidant-dependent and independent manners
por: Liu, Zhiyuan, et al.
Publicado: (2021)

m(6)A demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small-cell lung cancer
por: Tsuchiya, Kazuo, et al.
Publicado: (2022)

ESCO2 promotes hypopharyngeal carcinoma progression in a STAT1-dependent manner
por: Hu, Juan, et al.
Publicado: (2023)

Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
por: von Otter, Malin, et al.
Publicado: (2010)

RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
por: Qu, Jianwei, et al.
Publicado: (2022)

TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis
por: Yang, Ruotong, et al.
Publicado: (2023)

Evaluation of the Association of IGF2BP2 Variants With Type 2 Diabetes in French Caucasians
por: Duesing, Konsta, et al.
Publicado: (2008)

Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer
por: Ye, Mujie, et al.
Publicado: (2023)

Functional Polymorphism in the NFE2L2 Gene Associated With Tuberculosis Susceptibility
por: Ji, Guiyi, et al.
Publicado: (2021)

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target
por: Shantha Kumara, HMC, et al.
Publicado: (2015)

Prognosis Value of Platelet Counts, Albumin and Neutrophil-Lymphocyte Ratio of Locoregional Recurrence in Patients with Operable Head and Neck Squamous Cell Carcinoma
por: Ye, Jing, et al.
Publicado: (2020)

Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes
por: Pajares, Marta, et al.
Publicado: (2016)

IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer
por: Chou, Chia-Hsuan, et al.
Publicado: (2020)

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
por: Hu, Xiaoge, et al.
Publicado: (2019)

Targeting PD-L1 (Programmed death-ligand 1) and inhibiting the expression of IGF2BP2 (Insulin-like growth factor 2 mRNA-binding protein 2) affect the proliferation and apoptosis of hypopharyngeal carcinoma cells
por: Yang, Xudong, et al.
Publicado: (2021)

Interactive Effect of IGF2BP2 rs4402960 Variant, Smoking and Type 2 Diabetes
por: Nfor, Oswald Ndi, et al.
Publicado: (2020)

Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma
por: Barghash, Ahmad, et al.
Publicado: (2016)

Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer
por: Li, Yue, et al.
Publicado: (2019)

The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome.
por: Tsukuda, Senko, et al.
Publicado: (2023)

IGF2BP1 promotes SRF-dependent transcription in cancer in a m(6)A- and miRNA-dependent manner
por: Müller, Simon, et al.
Publicado: (2019)

NFE2L2 variations reduce antioxidant response in patients with Parkinson disease
por: Gui, YaXing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b2889hm5k0v125blrv9o77ebrn